立体定向放射治疗肺癌脑转移的疗效观察及护理  

Efficacy and nursing of stereotactic radiotherapy in lung cancer patients with brain metastasis

作　　者：张晓霞[1] 兰英[1] 殷文蓉[1] 

机构地区：[1]四川大学华西医院肿瘤中心放疗科,成都610041

出　　处：《中国肺癌杂志》2007年第5期395-397,共3页Chinese Journal of Lung Cancer

摘　　要：背景与目的 肺癌脑转移发生率高,放射治疗是此类患者的主要治疗方法。本研究的目的是观察立体定向放射治疗对肺癌脑转移的疗效,并探讨积极有效的护理的价值。方法 2002年6月-2006年12月43例肺癌脑转移患者接受了立体定向放射治疗,放疗期间根据病情采取针对性护理。结果 全部患者顺利完成放疗,无严重副反应和并发症发生。放疗后颅内病灶控制率为81.4%,神经系统症状缓解率为76.7%,KPS评分显著上升。生存时间2-34个月,中位生存时间8.5个月,半年、1年、2年生存率分别为58.9%、26.2%、6.0%。结论 对肺癌脑转移患者给予立体定向放射治疗,配合积极有效的护理,患者可顺利完成放疗,并达到缓解症状、延长生存期和提高生活质量的预期目的。[Abstract] Background and objective It has a high incidence that brain metastasis derives from lung cancer. Radiotherapy is the best choice for those patients who suffered from lung cancer with brain metastasis. The aim of this study is to observe the efficacy of stereotactic radiotherapy （SRT） in lung cancer patients with brain metastasis and explore the nursing for those patients. Methods From June, 2002 to December, 2006, SRT was carried out in 43 patients who suffered from lung cancer with brain metastasis, as well as special nursing according to their conditions. Results All the patients finished SRT and no serious adverse reaction and complication was found. Local control rate was 81. 4%, the nervous system symptom relief rate was 76.7% and KPS score was raised significantly. Survival time ranged from 2 to 34 months, median survival time was 8. 5 months, and 6-month, 1- and 2-year survival rate was 58.9%, 26.2% and 6.0% respectively. Conclusion SRT is one of the effective palliation treatments for the patients who suffered from lung cancer with brain metastasis, which may prolong their survival and improve their quality of life with the assistance of effective nursing.

关 键 词：肺癌脑转移 立体定向放射治疗 护理 疗效 

分 类 号：R473.73[医药卫生—护理学]